PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

Novavax’s Nuvaxovid Receives Expanded Authorization for COVID-19 in Canada

Novavax’s Nuvaxovid Receives Expanded Authorization for COVID-19 in Canada

November 21, 2022

Dr. Navdeep Tangri & Helen Yeh Shares Insights from the Data Presented at ASN Kidney Week 2022 on the Importance of Earlier Screening & Diagnosis of Chronic Kidney Disease

Dr. Navdeep Tangri & Helen Yeh Shares Insights from the Data Presented at ASN Kidney Week 2022 on the Importance of Earlier Screen...

November 21, 2022

HiFiBiO Therapeutics Entered into a Clinical Trial Supply Agreement with Novartis to Evaluate HFB200603 + Tislelizumab for DIS Selected Advanced Solid Tumors

HiFiBiO Therapeutics Entered into a Clinical Trial Supply Agreement with Novartis to Evaluate HFB200603 + Tislelizumab for DIS Sel...

November 21, 2022

Provention Bio's TZIELD (teplizumab-mzwv) Receives the US FDA's Approval of BLA for the Treatment of Stage 2 Type 1 Diabetes

Provention Bio's TZIELD (teplizumab-mzwv) Receives the US FDA's Approval of BLA for the Treatment of Stage 2 Type 1 Diabetes

November 21, 2022

Adaptimmune Reports P-II (SPEARHEAD-1) Trial Results of Afami-cel for the Treatment of Synovial Sarcoma at CTOS 2022

Adaptimmune Reports P-II (SPEARHEAD-1) Trial Results of Afami-cel for the Treatment of Synovial Sarcoma at CTOS 2022

November 21, 2022

Pfizer and BioNTech Report Results of Omicron BA.4/BA.5-Adapted Bivalent Booster for the Treatment of COVID-19

Pfizer and BioNTech Report Results of Omicron BA.4/BA.5-Adapted Bivalent Booster for the Treatment of COVID-19

November 21, 2022

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
[email protected]
Newsletter

Our Information

Follow Us